Research autopsy programmes in oncology: shared experience from 14 centres across the world
The Journal of Pathology · 2024-06 · 263 (2) · 150-165
DOI: 10.1002/path.6271 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Pathology, online erschienen am 29.03.2024. Verfasst von Tatjana Geukens und 45 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Autopsy, Neoplasms, Medical Oncology. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
While there is a great clinical need to understand the biology of metastatic cancer in order to treat it more effectively, research is hampered by limited sample availability. Research autopsy programmes can crucially advance the field through synchronous, extensive, and high‐volume sample collection. However, it remains an underused strategy in translational research. Via an extensive questionnaire, we collected information on the study design, enrolment strategy, study conduct, sample and data management, and challenges and opportunities of research autopsy programmes in oncology worldwide. Fourteen programmes participated in this study. Eight programmes operated 24 h/7 days, resulting in a lower median postmortem interval (time between death and start of the autopsy, 4 h) compared with those operating during working hours (9 h). Most programmes ( n = 10) succeeded in collecting all samples within a median of 12 h after death. A large number of tumour sites were sampled during each autopsy (median 15.5 per patient). The median number of samples collected per patient was 58, including different processing methods for tumour samples but also non‐tumour tissues and liquid biopsies. Unique biological insights derived from these samples included metastatic progression, treatment resistance, disease heterogeneity, tumour dormancy, interactions with the tumour micro‐environment, and tumour representation in liquid biopsies. Tumour patient‐derived xenograft (PDX) or organoid (PDO) models were additionally established, allowing for drug discovery and treatment sensitivity assays. Apart from the opportunities and achievements, we also present the challenges related with postmortem sample collections and strategies to overcome them, based on the shared experience of these 14 programmes. Through this work, we hope to increase the transparency of postmortem tissue donation, to encourage and aid the creation of new programmes, and to foster collaborations on these unique sample collections. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
- Stanford University School of Medicine, Palo Alto, CA, USA.
- University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA.
- Peter MacCallum Cancer Centre, Melbourne, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
- Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA.
ORCID-Profile: Rohit Mehra, Wouter Van Den Bogaert, Giuseppe Floris, Christine Desmedt
Förderung
- NIEHS NIH HHS
- NCI NIH HHS
- NIA NIH HHS
- Susan G. Komen
- Peter MacCallum Foundation
- Breast Cancer Research Foundation
Zitieren
APA
Geukens, T., Maetens, M., Hooper, J. E., Oesterreich, S., Lee, A. V., Miller, L., Atkinson, J. M., Rosenzweig, M., Puhalla, S., Thorne, H., Devereux, L., Bowtell, D., Loi, S., Bacon, E. R., Ihle, K., Song, M., Rodriguez-Rodriguez, L., Welm, A. L., Gauchay, L., …, & Desmedt, C. (2024). Research autopsy programmes in oncology: shared experience from 14 centres across the world. The Journal of Pathology, 263(2), 150-165. https://doi.org/10.1002/path.6271
Vancouver
Geukens T, Maetens M, Hooper JE, Oesterreich S, Lee AV, Miller L, et al. Research autopsy programmes in oncology: shared experience from 14 centres across the world. The Journal of Pathology. 2024;263(2):150-165. doi:10.1002/path.6271
BibTeX
@article{Geukens2024,
author = {Geukens, Tatjana and Maetens, Marion and Hooper, Jody E and Oesterreich, Steffi and Lee, Adrian V and Miller, Lori and Atkinson, Jenny M and Rosenzweig, Margaret and Puhalla, Shannon and Thorne, Heather and Devereux, Lisa and Bowtell, David and Loi, Sherene and Bacon, Eliza R and Ihle, Kena and Song, Mihae and Rodriguez-Rodriguez, Lorna and Welm, Alana L and Gauchay, Lisa and Murali, Rajmohan and Chanda, Pharto and Karacay, Ali and Naceur-Lombardelli, Cristina and Bridger, Hayley and Swanton, Charles and Jamal-Hanjani, Mariam and Kollath, Lori and True, Lawrence and Morrissey, Colm and Chambers, Meagan and Chinnaiyan, Arul M and Wilson, Allecia and Mehra, Rohit and Reichert, Zachery and Carey, Lisa A and Perou, Charles M and Kelly, Erin and Maeda, Daichi and Goto, Akiteru and Kulka, Janina and Székely, Borbála and Szasz, A Marcell and Tőkés, Anna-Mária and Van Den Bogaert, Wouter and Floris, Giuseppe and Desmedt, Christine},
title = {Research autopsy programmes in oncology: shared experience from 14 centres across the world},
journal = {The Journal of Pathology},
year = {2024},
volume = {263},
number = {2},
pages = {150--165},
doi = {10.1002/path.6271}
}
EUVIMED